A Canadian court has refused to dismiss an ongoing class action lawsuit against Gilead Sciences over alleged negligence claims relating to its HIV drug, a decision that could “significantly reshape” ...

Arizona’s lawsuit against L’Oréal USA, Inc. and associated companies alleges the company concealed cancer risks tied to chemical hair relaxers marketed to women and girls of African descent.

Abbott closes one door on its infant formula problems linked to a widespread recall and supply crisis in the US but still faces class action complaints alleging harm from the products.

Peerbridge plans to introduce its newly FDA-cleared second-generation Cor MDx patch for detecting heart arrythmias to health ...

Strong PFS data and oral convenience may enable zipalertinib to compete against J&J’s bispecific Rybrevant in NSCLC patients ...

The US FDA approved the myostatin inhibitor Isembyld (apitegromab) on top of SMN-targeted therapies for spinal muscular ...

AstraZeneca and Daiichi Sankyo’s HER2-targeting ADC showed a PFS benefit in first-line treatment of HER2-mutant non-small ...

VDGH chief executive Martin Walger is putting his hopes on positive EU trilog outcomes regarding the IVDR and MDR amendments, ...

Medicare has finalized expanded coverage for TAVR, including certain asymptomatic patients with severe aortic stenosis, while ...

Tandem's $100m funding will be used to accelerate the adoption of AI across European healthcare, expanding from an AI medical ...

Mike Davis used his first public address as permanent CDER director to outline realigned incentives that will favor ...

The US FDA pleads with online cosmetics sellers to cease requests for product registration certificates. Separately, IFRA has ...